Join to view full profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Behl is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2006 - 2009- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Christian Medical College LudhianaClass of 1996
Certifications & Licensure
CA State Medical License 2009 - 2027
MN State Medical License 2025 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
- Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer Start of enrollment: 2020 Aug 13
- Ashwagandha for Cognitive Dysfunction Start of enrollment: 2023 Jan 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Use of adjuvant immunotherapy and early overall survival in stage III Merkel cell carcinoma.Hue T T Tran, Frank Z Jing, Duc V Le, Raslina Shrestha, Jerry D Brewer
Journal of the European Academy of Dermatology and Venereology. 2026-10-24 - Biologic agents for immune checkpoint inhibitor-associated cutaneous adverse events: A retrospective cohort study at a tertiary referral center.Duc V Le, Hue T T Tran, Raslina Shrestha, Dan S Childs, Deepti Behl
Journal of the American Academy of Dermatology. 2026-09-01 - Marital status and its association with vulvar melanoma outcomes.Hue T T Tran, Duc V Le, Raslina Shrestha, David A Wetter, Deepti Behl
International Journal of Gynecological Cancer. 2026-09-01
Press Mentions
The Cancer Treatment Within YouNovember 20th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
